Kiran Mazumdar-Shaw

The experts deliver learnings, takeaways and way forward for pharma industry

Biosimilars up 10 per cent at Rs 758 crores and research services up 41 per cent at Rs 595 crores

Krishnan will head a nine-member executive council that was elected last January for a three-year term starting on April 1, 2021

Biocon Biologics announced that Shreehas Tambe has been promoted to the position of Deputy Chief Executive Officer of Biocon…

Biocon Biologics, a subsidiary of Biocon has signed an agreement with the Clinton Health Access Initiative (CHAI) to expand…

Professor Piot is the Director of the London School of Hygiene & Tropical Medicine and the Handa Professor of Global Health

The facility will currently focus on autologous cell therapies including CAR-T cell therapy for lymphomas and leukaemias

Biocon Biologics had raised over $255 million from global investors from Jan to Nov 2020

Goldman Sachs will be issued Optionally Convertible Debentures at a post money equity valuation of $3.94 billion

The Top 5 global players in this year’s list are Regeneron, Alnylam, Incyte, Syngenta and Biocon